IP Library Granted Patent US 12,569,634
Granted Patent B2
US 12,569,634 · App. 17/470,010 · Granted Mar 10, 2026

Systems and/or methods for guiding transitions between therapy modes in connection with treatment and/or diagnosis of sleep-disordered breathing

Inventors: Andrew Blackwell (Sydney, AU); Gerard Michael O'Connor (Sydney, AU); Marita Elizabeth Barraclough (Sydney, AU)
Assignee: ResMed Pty Ltd
A61M16/0057A61M16/024A61M2205/3553A61M2205/3584A61M2205/3592A61M2205/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,634
App. No.
17/470,010
Granted
Mar 10, 2026
Kind
B2
Abstract

In certain example embodiments, a system and/or method of guiding transitions between therapy modes in connection with the treatment and/or diagnosis of a patient for a respiratory disorder is/are provided. Respiratory disorder treatment according to a first therapy mode is provided. Input indicating a second therapy mode to be transitioned to following provision of the first therapy mode is received, with the second therapy mode being different from the first therapy mode. At least one default treatment parameter suitable for the second therapy mode is assigned or calculated. Each default treatment parameter of the second therapy mode is presented, with each default treatment parameter being adjustable by an operator during the presenting. Transitioning from the first therapy mode to the second therapy mode is performed by providing respiratory disorder treatment in accordance with the second therapy mode and each default treatment parameter and any adjustments made thereto prior to the transitioning. Advantageously, the chances of a patient being disturbed by transitioning from mode-to-mode are reduced.

Claims (42)

1 . A flow generator configured to supply a plurality of therapy modes to a patient suffering from a respiratory disorder, comprising:

an input mechanism configured to receive input indicating a second therapy mode to be transitioned to following provision of a first therapy mode, the input being received subsequent to initiation of the first therapy mode, said second therapy mode being different from said first therapy mode; and

a processor configured to guide the transition from the first therapy mode to the second therapy mode by transitioning from the first therapy mode to the second therapy mode in accordance with at least one default treatment parameter suitable for the second therapy mode and any changes made by an operator to each said default treatment parameter prior to the transition, the at least one default treatment parameter including a first default treatment parameter,

wherein the processor is configured to accomplish the transition by adjusting the first default treatment parameter in a stepwise manner from an initial level associated with the first therapy mode through at least one intermediate level prior to reaching a second level selected for the second therapy mode,

wherein the first therapy mode is a first Continuous Positive Airway Pressure (CPAP) mode, a first AutoSet mode, a first BiLevel mode, a first VAUTO mode, a first Spontaneous(S) mode, or a first Timed (T) mode,

wherein the second therapy mode is a second Continuous Positive Airway Pressure (CPAP) mode, a second AutoSet mode, a second BiLevel mode, a second VAUTO mode, a second Spontaneous(S) mode, or a second Timed (T) mode,

wherein each of the first CPAP mode and the second CPAP mode is configured to provide continuous positive airway pressure to a patient,

wherein each of the first AutoSet mode and the second AutoSet mode is configured to provide positive airway pressure to the patient where a pressure level of the positive airway pressure is automatically tuned,

wherein each of the first BiLevel mode and the second BiLevel mode is configured to provide two levels of positive airway pressure, each of the first BiLevel mode and the second BiLevel mode being configured to provide a first level of positive airway pressure during inspiration by the patient and a second level of positive airway pressure during expiration by the patient,

wherein each of the first VAUTO mode and the second VAUTO mode is configured to provide two levels of positive airway pressure, each of the first VAUTO mode and the second VAUTO mode being configured to provide a first level of positive airway pressure during inspiration by the patient and a second level of positive airway pressure during expiration by the patient, the first and second levels of positive airway pressure being automatically tuned,

wherein each of the first S mode and the second S mode is configured to detect inspiratory effort by the patient and in response provide an inspiratory positive airway pressure level to the patient, and

wherein each of the first T mode and the second T mode is configured to provide an inspiratory positive airway pressure level and an expiratory positive airway pressure level to the patient on a predetermined timed basis.

2 . The flow generator of claim 1 , wherein the at least one default treatment parameter is at least initially provided by a manufacturer of the flow generator.

3 . The flow generator of claim 2 , wherein the at least one treatment parameter that is at least initially provided by the manufacturer of the flow generator is updatable by a sleep lab.

4 . The flow generator of claim 1 , wherein the processor is configured to specify one or more parameters for the second therapy mode, each said parameter lacking a precedent value in the first therapy mode.

5 . The flow generator of claim 1 , wherein the input mechanism is configured to receive the input after the first therapy mode is initially provided.

6 . The flow generator of claim 1 , further comprising a display configured to display each said default treatment parameter.

7 . The flow generator of claim 6 , wherein the display is a screen configured to output readable text.

8 . The flow generator of claim 1 , further comprising a first wireless transmitter configured to wirelessly communicate with a second wireless transmitter remote from the first wireless transmitter, said input configured to be communicated wirelessly from the second wireless transmitter to the first wireless transmitter.

9 . The flow generator of claim 1 , further comprising a first wired connection configured to communicate via a wired network with a computer terminal remote from the first wired connection, said input configured to be communicated via the wired network from the computer terminal to the first wired connection.

10 . The flow generator of claim 1 , further comprising a least one transducer configured to monitor at least one process including volumetric flow rate, pressure, snore, flow generator rotational speed, and motor parameters.

11 . The flow generator of claim 1 , further comprising an impeller configured to supply a first therapeutically effective pressure between 3-20 cm H2O during the first therapy mode, and wherein the impeller is configured to supply a second therapeutically effective pressure between 3-20 cm H2O during the second therapy mode.

12 . The flow generator of claim 11 , wherein the processor is configured to selectively communicate with the impeller via a motor.

13 . The flow generator of claim 1 , wherein the flow generator includes a sensor configured to monitor a parameter that includes at least one of snoring sound, lack of breathing effort, progressiveness of increased apneas in the first therapy mode, the sensor configured to output a signal based off of the monitored parameter, the signal configured to recommend the second therapy mode.

14 . The flow generator of claim 1 , wherein the processor is configured to provide at least one constant treatment parameter suitable for the second therapy mode that remains the same from the first therapy mode.

15 . The flow generator of claim 1 , wherein the first therapy mode is the first CPAP mode and the second therapy mode is the second AutoSet mode.

16 . The flow generator of claim 1 , wherein the processor is further configured to provide one or more further transition(s) between therapy modes.

17 . The flow generator of claim 16 , wherein each said further transition is provided according to a predefined progression.

18 . The flow generator of claim 1 , wherein the processor is configured to guide the transition from the first therapy mode to the second therapy without the input mechanism receiving an input from an operator.

19 . The flow generator of claim 1 , wherein the input mechanism is a user interface configured to directly receive said input.

20 . A flow generator configured to supply a plurality of therapy modes to a patient suffering from a respiratory disorder, comprising:

means for receiving input indicating a second therapy mode to be transitioned to following provision of a first therapy mode, the input being received subsequent to initiation of the first therapy mode, said second therapy mode being different from said first therapy mode; and

means for transitioning from the first therapy mode to the second therapy mode in accordance with at least one default treatment parameter suitable for the second therapy mode and any changes made by an operator to each said default treatment parameter prior to the transition, the at least one default treatment parameter including a first default treatment parameter,

wherein the means for transitioning is configured to adjust the first default treatment parameter in a stepwise manner from an initial level associated with the first therapy mode through at least one intermediate level prior to reaching a second level selected for the second therapy mode,

wherein the first therapy mode is a first Continuous Positive Airway Pressure (CPAP) mode, a first AutoSet mode, a first BiLevel mode, a first VAUTO mode, a first Spontaneous(S) mode, or a first Timed (T) mode,

wherein the second therapy mode is a second Continuous Positive Airway Pressure (CPAP) mode, a second AutoSet mode, a second BiLevel mode, a second VAUTO mode, a second Spontaneous(S) mode, or a second Timed (T) mode,

wherein each of the first CPAP mode and the second CPAP mode is configured to provide continuous positive airway pressure to a patient,

wherein each of the first AutoSet mode and the second AutoSet mode is configured to provide positive airway pressure to the patient where a pressure level of the positive airway pressure is automatically tuned,

wherein each of the first BiLevel mode and the second BiLevel mode is configured to provide two levels of positive airway pressure, each of the first BiLevel mode and the second BiLevel mode being configured to provide a first level of positive airway pressure during inspiration by the patient and a second level of positive airway pressure during expiration by the patient,

wherein each of the first VAUTO mode and the second VAUTO mode is configured to provide two levels of positive airway pressure, each of the first VAUTO mode and the second VAUTO mode being configured to provide a first level of positive airway pressure during inspiration by the patient and a second level of positive airway pressure during expiration by the patient, the first and second levels of positive airway pressure being automatically tuned,

wherein each of the first S mode and the second S mode is configured to detect inspiratory effort by the patient and in response provide an inspiratory positive airway pressure level to the patient, and

wherein each of the first T mode and the second T mode is configured to provide an inspiratory positive airway pressure level and an expiratory positive airway pressure level to the patient on a predetermined timed basis.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2021
From: BLACKWELL, ANDREW; O'CONNOR, GERARD MICHAEL; BARRACLOUGH, MARITA ELIZABETH
To: RESMED LIMITED
Reel/Frame 057423/0739 →
CHANGE OF NAME AND CHANGE OF ADDRESS Recorded Sep 9, 2021
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 057527/0169 →
Continuity (5)
Continuation 15946514 · Apr 5, 2018
Continuation 15446704 · Mar 1, 2017
Continuation 12550489 · Aug 31, 2009
Provisional Application 61193163 · Oct 31, 2008
Related Publication 20210402117A1 · Dec 30, 2021
References Cited (58)
US 3916889A · Russell · 1975 [cited by examiner]
US 5117819A · Servidio · 1992 [cited by examiner]
US 5245995A · Sullivan · 1993 [cited by examiner]
US 5598838A · Servidio · 1997 [cited by examiner]
US 5664562A · Bourdon · 1997 [cited by applicant]
US 5678539A · Schubert · 1997 [cited by examiner]
US 5865173A · Froehlich · 1999 [cited by applicant]
US 5881717A · Isaza · 1999 [cited by examiner]
US 5881723A · Wallace · 1999 [cited by examiner]
US 5884622A · Younes · 1999 [cited by examiner]
US 5970975A · Estes et al. · 1999 [cited by applicant]
US 6148814A · Clemmer · 2000 [cited by examiner]
US 6158432A · Biondi · 2000 [cited by examiner]
US 6406426B1 · Reuss · 2002 [cited by examiner]
US 6530372B1 · Madaus et al. · 2003 [cited by applicant]
US 6543449B1 · Woodring · 2003 [cited by examiner]
US 9586014B2 · Blackwell et al. · 2017 [cited by applicant]
US 20010004893A1 · Biondi · 2001 [cited by examiner]
US 20020005197A1 · DeVries · 2002 [cited by examiner]
US 20020091454A1 · Vasko · 2002 [cited by examiner]
US 20030062045A1 · Woodring · 2003 [cited by examiner]
US 20040118403A1 · O'Connor · 2004 [cited by examiner]
US 20050005937A1 · Farrugia · 2005 [cited by examiner]
US 20050166922A1 · Knepper · 2005 [cited by applicant]
US 20050182358A1 · Veit · 2005 [cited by examiner]
US 20050211246A1 · Beck · 2005 [cited by examiner]
US 20050261660A1 · Choi · 2005 [cited by examiner]
US 20060042638A1 · Niklewski · 2006 [cited by examiner]
US 20060162727A1 · Biondi et al. · 2006 [cited by applicant]
US 20070000491A1 · Chalvignac · 2007 [cited by examiner]
US 20070017515A1 · Wallace · 2007 [cited by examiner]
US 20070215155A1 · Marx · 2007 [cited by examiner]
US 20070277827A1 · Bordewick · 2007 [cited by examiner]
US 20080011301A1 · Qian · 2008 [cited by examiner]
US 20080041383A1 · Matthews · 2008 [cited by applicant]
US 20080053438A1 · DeVries · 2008 [cited by examiner]
US 20080072902A1 · Setzer · 2008 [cited by examiner]
US 20080091117A1 · Choncholas · 2008 [cited by examiner]
US 20080185009A1 · Choncholas · 2008 [cited by examiner]
US 20080200775A1 · Lynn · 2008 [cited by examiner]
US 20090065007A1 · Wilkinson · 2009 [cited by examiner]
US 20090107498A1 · Plattner · 2009 [cited by examiner]
US 20090205663A1 · Vandine et al. · 2009 [cited by applicant]
US 20090293876A1 · Soliman · 2009 [cited by examiner]
US 20100108064A1 · Blackwell et al. · 2010 [cited by applicant]
US 20100218766A1 · Milne · 2010 [cited by applicant]
US 20120024286A1 · Boring · 2012 [cited by applicant]
US 20170173284A1 · Blackwell et al. · 2017 [cited by applicant]
US 20180236192A1 · Blackwell et al. · 2018 [cited by applicant]
WO WO9841267A1 · 1998 [cited by applicant]
WO WO9913932A1 · 1999 [cited by examiner]
WO WO02058619A2 · 2002 [cited by applicant]
WO WO2005028029A2 · 2005 [cited by examiner]
WO WO2005107589A1 · 2005 [cited by examiner]
WO WO2006084456A1 · 2006 [cited by applicant]
WO WO2008148134A1 · 2008 [cited by examiner]
Feb. 18, 2010 European Search Report issued for European Patent Application No. 09169044.6. [cited by applicant]
Apr. 14, 2014 Office Action issued in corresponding European Application No. 09169044.6. [cited by applicant]